Leah Cream

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i> - or <i>BRCA2</i> -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

George Somlo, Paul Frankel, Banu Arun et al. · Clinical Cancer Research · 2017 · 99 citations · Full text

Medicine, Oncology, Pharmacology +15

Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients

Kathleen M. Sturgeon, Amanda M. Smith, Elizabeth Federici et al. · BMC Sports Science Medicine and Rehabilitation · 2022 · 42 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +17

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device

Jean‐Nicolas Gallant, Elizabeth Matthew, Ramdane Harouaka et al. · Cell Cycle · 2013 · 21 citations · Full text

Engineering, Biomedical Engineering, Cell Biology +17

Phase II trial of single agent PARP inhibitor ABT-888 (veliparib [vel]) followed by postprogression therapy of vel with carboplatin (carb) in patients (pts) with stage BRCA-associated metastatic breast cancer (MBC): California Cancer Consortium trial PHII-96.

George Somlo, Paul Frankel, Thehang Luu et al. · Journal of Clinical Oncology · 2014 · 17 citations

Medicine, Oncology, Pharmacology +17

Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma

Joseph A. Lewcun, Colette Pameijer, Rena Kass et al. · International Journal of Surgery Case Reports · 2020 · 14 citations · Full text

Medicine, Oncology, Surgery +17